SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001618835-23-000011
Filing Date
2023-02-23
Accepted
2023-02-23 15:29:47
Documents
16
Period of Report
2023-02-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evfm-20230217.htm   iXBRL 8-K 77614
2 EX-10.1 a101evfmgunnarspapipen-wfe.htm EX-10.1 359939
3 EX-10.2 a102evfmsecuredformofnoteg.htm EX-10.2 358647
4 EX-10.3 a103evfmdecformofwarrantfe.htm EX-10.3 232163
5 EX-10.4 a104evfmdecpipeformofrrano.htm EX-10.4 193435
  Complete submission text file 0001618835-23-000011.txt   1600208

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evfm-20230217.xsd EX-101.SCH 1896
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evfm-20230217_lab.xml EX-101.LAB 23892
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evfm-20230217_pre.xml EX-101.PRE 12519
10 EXTRACTED XBRL INSTANCE DOCUMENT evfm-20230217_htm.xml XML 10798
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 23659324
SIC: 2834 Pharmaceutical Preparations